A phase II multicenter trial of weekly herceptin with navelbine in chemonaive patients with her2 positive metastatic breast cancer

Phase Ii ◽

Metastatic Breast ◽

Multicenter Trial ◽

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-021-06216-5 ◽

2021 ◽

Author(s):

Zijing Wang ◽

Jiaxuan Liu ◽

Fei Ma ◽

Jiayu Wang ◽

Yang Luo ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Efficacy Study ◽

Her2 Positive ◽

Safety And Efficacy ◽

Metronomic Vinorelbine

SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdx365.084 ◽

2017 ◽

Vol 28 ◽

pp. v106-v107 ◽

Cited By ~ 3

Author(s):

P. Villagrasa Gonzalez ◽

A. Prat ◽

M. Oliveira ◽

L. de la Pena ◽

X. Gonzalez ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

232 Final Results of a Phase II Study of the Combination of Oral Vinorelbine (NVBo), Capecitabine (X) and Trastuzumab (H) in HER2-positive Metastatic Breast Cancer (MBC)

European Journal of Cancer ◽

10.1016/s0959-8049(12)70300-3 ◽

2012 ◽

Vol 48 ◽

pp. S110

Author(s):

L. Petruzelka ◽

V. Ganju ◽

P.F. Conte ◽

N. Tubiana-Mathieu ◽

F. Majois ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Her2 Positive ◽

Oral Vinorelbine

A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer

Cancer Investigation ◽

10.3109/07357901003631031 ◽

2010 ◽

Vol 28 (8) ◽

pp. 865-871 ◽

Cited By ~ 5

Author(s):

Denise A. Yardley ◽

Davey Daniel ◽

Michael Stipanov ◽

D. Randolph Drosick ◽

Mark Mainwaring ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4203-y ◽

2017 ◽

Vol 163 (3) ◽

pp. 507-515 ◽

Cited By ~ 3

Author(s):

Konstantinos Tryfonidis ◽

◽

S. Marreaud ◽

H. Khaled ◽

B. De Valk ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Extracellular Domain ◽

Cardiac Safety ◽

Her2 Positive ◽

Serial Serum

Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy

Annals of Oncology ◽

10.1093/annonc/mdx365.015 ◽

2017 ◽

Vol 28 ◽

pp. v81

Author(s):

N.M. Iyengar ◽

L.M. Smyth ◽

D. Lake ◽

A. Gucalp ◽

J.C. Singh ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Abstract OT1-1-13: A phase II study with lead-in safety cohort of cabazitaxel plus lapatinib as therapy for patients with HER2-positive metastatic breast cancer (MBC) and intracranial metastases

10.1158/0008-5472.sabcs13-ot1-1-13 ◽

2013 ◽

Author(s):

DA Yardley ◽

JD Hainsworth ◽

E Hamilton ◽

LL Hart ◽

M Shastry ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Her2 Positive ◽

Intracranial Metastases

Abstract PD3-08: A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab

10.1158/1538-7445.sabcs17-pd3-08 ◽

2018 ◽

Cited By ~ 4

Author(s):

B Xu ◽

F Ma ◽

Q Ouyang ◽

W Li ◽

Z Jiang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her2 Positive ◽

Randomized Phase Ii ◽

Previously Treated

Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer

10.1158/1538-7445.sabcs18-pd3-03 ◽

2019 ◽

Cited By ~ 5

Author(s):

E Ciruelos ◽

P Villagrasa ◽

L Paré ◽

M Oliveira ◽

S Pernas ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Her2 Positive ◽

Stage 1